Skip to content

Spine Quantitative Computed Tomography (QCT)

Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00762879
Acronym
Spine QCT
Enrollment
127
Registered
2008-09-30
Start date
2008-04-30
Completion date
2017-06-30
Last updated
2017-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Idiopathic Arthritis

Keywords

Juvenile Idiopathic Arthritis, JIA, Arthritis, Osteoporosis, Osteoporosis in Children

Brief summary

The purpose of this study is to compare healthy children to children who have a chronic illness called Juvenile Idiopathic Arthritis (JIA). JIA is a childhood disease that causes swollen joints that are often stiff and painful. JIA affects about 1 in 1,000 children age 16 and younger.

Detailed description

Children with chronic illnesses are at risk for bone fragility due to inflammation, glucocorticoid therapy, physical activity limitation, malnutrition, and pubertal delay. The impact of low bone mass during childhood may be immediate, resulting in childhood fractures, or delayed, due to suboptimal peak bone mass attainment.

Interventions

None listed

Sponsors

Children's Hospital of Philadelphia
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
5 Years to 21 Years
Healthy volunteers
Yes

Inclusion criteria

* for JIA patients: subjects age 5-21 Drawn from Dr. Burnham's prospective cohort study of bone health in 101 children with arthritis. * for Control patients: subjects age 5-21 Controls will be a 50% male/female

Exclusion criteria

* for JIA patients: Subjects with JIA will be excluded if they have conditions or drug exposure unrelated to JIA and known to impact growth or bone health. * for Control patients: Chronic disease or syndrome known to affect growth or bone health, prematurity (\<37 weeks gestation), or use of any medication known to affect growth.

Design outcomes

Primary

MeasureTime frame
Lumbar spine volumetric Bone Mineral Density (vBMD) and vertebral size will vary according to sex, age and pubertal stage.same day

Secondary

MeasureTime frame
Children with JIA will have lower vertebral stiffness and strength, compared with controls.same day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026